Introduction
According to statistical sources, there were more than 960,000 new cases of gastric cancer worldwide in 2022, with about 660,000 fatalities. Gastric cancer is the fifth most commonly diagnosed malignancy and the fifth leading cause of cancer-related death globally. It can be divided into two subsites based on anatomical location: cardia gastric cancer (CGC) and non-cardia gastric cancer (NCGC).1 East Asia has the highest incidence of CGC in the world, and the incidence continues to show an upward trend.2
East Asia bears a substantial burden of infection-attributable cancer, including a considerable burden of gastric cancer attributable to Helicobacter pylori (H. pylori) infection.3 Several studies have identified a substantial connection between H. pylori infection and NCGC.4 Correa described the progression from H. pylori infection, chronic gastritis, chronic atrophic gastritis, intestinal metaplasia, and atypical hyperplasia to cancer, a pathway widely recognized in NCGC.5 Additionally, H. pylori eradication therapy has been shown to reduce the incidence of gastric cancer and related mortality.6 However, the relationship between H. pylori and CGC has remained controversial due to the unique anatomical position of CGC. A previous meta-analysis found a positive association in East Asia (odds ratio (OR) = 2.86, 95% confidence interval (CI) 2.26–3.63), but no significant association in the West (OR = 0.80, 95% CI 0.61–1.05).4 A recent multicenter prospective case-cohort study of 500,000 Chinese individuals found that an estimated 78.5% of NCGC and 62.1% of CGC can be attributed to H. pylori.7 However, the meta-analysis by Han et al.4 included studies with overlapping populations, which may have affected the results. Therefore, we aimed to evaluate the association between H. pylori infection and CGC in Asian populations.
Materials and methods
Search strategy
This systematic review and meta-analysis, registered in PROSPERO (CRD42023432339), was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 statement.8 All relevant studies were retrieved from three databases, including PubMed, Embase, and Web of Science, from their inception up to June 30, 2024. The following search terms were utilized: (“cardia” OR “proximal” OR “esophagogastric junction” OR “gastroesophageal junction”) AND (“neoplasm” OR “tumor” OR “cancer” OR “neoplasia” OR “carcinoma” OR “adenocarcinoma”) AND (“helicobacter pylori” OR “helicobacter nemestrinae” OR “campylobacter pylori” OR “H. pylori”). The detailed search strategy is provided in Table S1. Additionally, reference lists of relevant studies were checked to identify additional eligible studies. Two collaborators independently retrieved and evaluated the included studies, with disagreements resolved through consensus.
Inclusion and exclusion
All studies investigating the association between H. pylori infection and CGC in Asian populations were considered for screening. H. pylori detection methods included histology, rapid urease testing, culture, serology, or carbon-urea breath testing. The inclusion criteria were carefully defined: (1) the study type included case-control, cross-sectional, or cohort studies; (2) the exposure variable was H. pylori infection; (3) the case group involved CGC, and the control group was free of gastric cancer; (4) the population was from Asian countries; (5) studies provided sufficient data to estimate ORs or risk ratios; and (6) studies were published in English with full text available. We attempted to exclude other types of gastroesophageal junction carcinoma, such as distal esophageal adenocarcinoma. Case reports, letters, comments, reviews, and duplicate publications were excluded.
Data extraction
Two authors extracted detailed information from each included study, including the first author, publication year, country, patient characteristics (age, sex), study design (study type, follow-up time, method of H. pylori detection), definition of CGC, and details of the case and control groups (sample size, H. pylori infection status, outcomes).
Quality assessment and risk of bias
The methodological quality of eligible studies was independently assessed by two authors using the Newcastle-Ottawa Scale for case-control and cohort studies. Studies with scores ranging from seven to nine points were considered high quality. The risk of bias was assessed using ROBINS-E, a tool for non-randomized exposure studies, across several domains, including confounding, participant selection, exposure measurement, post-exposure interventions, missing data, outcome measurement, and selection of reported results.9 The overall risk of bias was categorized according to the ROBINS-E framework as low risk, some concerns, or high risk of bias.
Statistical analysis
Pooled ORs with 95% CIs were calculated to assess the association between H. pylori and CGC. ORs were extracted from the included studies. When adjusted estimates were unavailable, unadjusted ORs were calculated based on reported numbers of H. pylori-positive participants among cases and controls. The model used was based on heterogeneity results, which were analyzed using the chi-squared (χ2) test (Cochran’s Q) and the inconsistency index (I2). A random-effect model was employed when significant heterogeneity was identified (χ2P < 0.05 or I2 > 50%); otherwise, a fixed-effect model was applied. The aim of our analysis was to investigate the association between H. pylori infection and the risk of CGC. Subgroup analyses were conducted to explore effect modification based on study-level factors such as country, detection time of H. pylori, publication year, and duration of follow-up. For publication-year subgroup analysis, included studies were categorized into three periods: 1990–2000, 2001–2010, and 2011–2020. A leave-one-out sensitivity analysis was performed to assess the robustness of the pooled estimate. Publication bias was evaluated using funnel plots (Begg’s and Egger’s regression tests). All analyses were performed using Review Manager V.5.4 and STATA 15, with statistical significance defined as P < 0.05.
Results
Literature search and study characteristics
The PRISMA flowchart is presented in Figure 1. The preliminary literature search yielded a total of 4,308 articles from PubMed, Embase, and Web of Science. After removing 1,829 duplicates and excluding 2,393 unrelated articles based on title and abstract screening, 86 studies remained for full-text review. Finally, 24 full-text articles were included in the final analysis,7,10–32 with six studies involving duplicate populations among the 62 reports excluded after full-text assessment.33–38 The analysis involved 2,529 CGC cases and 52,556 control subjects. The study populations of the 24 included studies were from Asian countries (eight in China, nine in Japan, five in Korea, and two in Iran). The characteristics and quality scores of the eligible articles are shown in Table 1. Three studies were rated as high risk of bias, six had some concerns, and the remaining studies were considered low risk of bias (Fig. 2).
Table 1Characteristics of 24 studies
| First author | Year | Country | Design | Study period | Median follow-up (year) | H. pylori detection method | Age (year) | Male (%) | Number of CGC/control | Definition of CGC | NOS |
|---|
| Chen10 | 2009 | Taiwan, China | case-control | 2000–2009 | – | ELISA | CGC: 64.53 ± 2.17 Control: 63.27 ± 1.73 | 100 100 | 41/205 | within 5mm to GEJ | 8 |
| Cho11 | 2010 | Korea | case-control | 2003.6–2007.4 | – | ELISA | Case: 58.1 ± 12.0 Control: 53.0 ± 7.0 | 68.8 50.0 | 216/562 | within 2cm distal to GEJ | 8 |
| Derakhshan12 | 2008 | Iran | case-control | – | – | ELISA | CGC: 63.8 ± 7.1 Control: matched | 69.8 – | 53/53 | within 2cm distal to GEJ | 7 |
| Gao13 | 2022 | China | case-control | 2010–2014 | – | Immunoblot | CGC: 69.3 ± 7.9 Control: 66.3 ± 8.71 | 67.9 69.1 | 349/1,859 | within 5cm to GEJ | 8 |
| Horii14 | 2011 | Japan | case-control | 2000.8–2009.1 | – | histology/RUT/ELISA | CGC: 68.7 ± 9.5 Control: 61.7 ± 8.3 | 87.0 93.5 | 23/46 | within 2cm to GEJ | 8 |
| Inoue15 | 2020 | Japan | cohort | 1993–1994 | 18 | ELISA | 56.7 ± 8.3 | Case: 62.2 Control: 37.7 | 50/18,511 | anatomical position | 7 |
| Kamangar16 | 2007 | China | case-cohort | 1985–2001 | 10 | ELISA | CGC: 55.5 ± 7.7 Control: 51.9 ± 8.9 | 60.3 45.3 | 582/992 | proximal 3cm of the stomach | 8 |
| Kato17 | 2004 | Japan | case-control | – | – | ELISA | – | – | 86/6,578 | – | 7 |
| Kikuchi18 | 1995 | Japan | case-control | 1988–1992 | – | ELISA | GC: 20–40 Control: 15–44 | 45.7 43.6 | 35/203 | – | 7 |
| Kikuchi19 | 2000 | Japan | case-control | 1993.6–1995.7 | – | ELISA | Matched | GC: 66.1 Control: 51.3 | 186/1,007 | upper third of stomach | 7 |
| Kim20 | 1997 | Korea | case-control | 1994 | – | histology/RUT | GC: 57.3 Control: 56.9 | 65 61.9 | 12/160 | anatomical position | 6 |
| Kim21 | 2012 | Korea | case-control | 2003.6–2011.2 | – | histology/RUT/ELISA/tissue culture | Case: 60.3 ± 12.3 Control: 55.9 ± 11.9 | 67.3 33.7 | 60/270 | within 2cm below GEJ | 8 |
| Komoto22 | 1998 | Japan | case-control | 1991–1996 | – | ELISA | GC: 64.9 ± 1.2 Control: 62.4 ± 1.1 | 78.10 matched | 14/105 | within 20mm distal to GEJ | 8 |
| Lee23 | 1998 | Korea | case-control | 1992–1995 | – | RUT | GC: 54.4 Control: 40.5 | 67.4 71.7 | 17/113 | anatomical position | 7 |
| Shakeri24 | 2015 | Iran | case-control | 2004.12–2011.12 | – | ELISA, multiplex serology | CGC: 66.3 ± 11.1 Control: 64.5 ± 9.1 | 78.2 77.2 | 142/276 | - | 8 |
| Shibata25 | 1996 | Japan | case-control | – | – | histology | GC: 62 Control: 61.8 | 74 74 | 5/50 | upper third of stomach | 6 |
| Shin26 | 2005 | Korea | nested case-control | 1993–1999 | 2.6 | ELISA | Cases: 63.0 Control: matched | 66 matched | 6/24 | – | 8 |
| Suzuki27 | 2007 | Japan | nested case-control | 1970.1–2001.12 | 2 | ELISA | CGC: 70 ± 11 Control: – | 54.5 58.9 | 22/1,042 | – | 7 |
| Wu28 | 2009 | Taiwan, China | case-control | 2000–2007 | – | ELISA | GC: 63.2 ± 13.5 Control: 40.2 ± 6.2 | 62.8 51.6 | 29/395 | within 3cm distal to GEJ | 8 |
| Xie29 | 2020 | China | cross-sectional | 2014.1–2016.6 | – | 13C | CGC: 62.65 ± 5.27 Control: 53.30 ± 7.94 | 41.96 60.87 | 23/1,225 | – | 8 |
| Yamaoka30 | 1999 | Japan | case-control | – | – | ELISA | GC: 64.5 Control: matched | 72.7 matched | 23/23 | cardia and fundus | 6 |
| Yan32 | 2024 | China | case-cohort | 2015–2017 | 6.3 | 13C | 54.7 | 41.8 | 76/18,233 | – | 8 |
| Yang7 | 2021 | China | case-cohort | 2004.6–2008.7 | 10.1 | Immunoblot | CGC: 61.2 ± 8.6 Control: 59.1 ± 9.9 | 75.0 69.0 | 436/500 | – | 8 |
| Yuan31 | 1999 | China | case-cohort | 1986–1989 | 5.2 | ELISA | GC: 63.4 ± 5.6 Control: matched | – | 43/124 | – | 8 |
Pooled data
The pooled OR for the association between H. pylori and CGC in Asian countries was 2.20 (95% CI 1.73–2.80), with significant heterogeneity (I2 = 66%, P < 0.001), based on a random-effect model (Fig. 3).
Subgroup analysis
Stratification by country
The included studies were from Asian countries. A significant association between H. pylori and CGC was observed in East Asian countries, including China (OR = 2.12 [95% CI 1.63–2.77], I2 = 58%, P < 0.001), Japan (OR = 2.21 [95% CI 1.16–4.20], I2 = 78%, P = 0.02), and Korea (OR = 2.36 [95% CI 1.58–3.54], I2 = 15%, P < 0.01), but not in Iran (OR = 1.48 [95% CI 0.77–2.84], I2 = 0%, P = 0.24) (Fig. 4a).
Stratification by detection time of H. pylori
It is possible that H. pylori infection could be cleared as the cancer progresses.39,40 Identifying the status of H. pylori before malignancy develops can help reduce false-negative results to some extent. Seven studies, including five cohort or case-cohort studies and two nested case-control studies, assessed H. pylori status before CGC diagnosis. A comparable correlation was observed regardless of H. pylori detection time (OR = 2.03 [95% CI 1.32–3.12], I2 = 69%, P = 0.001; OR = 2.27 [95% CI 1.67–3.09], I2 = 66%, P < 0.001) (Fig. 4b).
Stratification by publication year
Between 1990–2000 and 2001–2010, there was a significant association between H. pylori and CGC (OR = 2.83 [95% CI 1.55–5.19], I2 = 58%, P < 0.001; OR = 2.10 [95% CI 1.55–2.86], I2 = 48%, P < 0.001). However, studies published from 2011 to 2020 showed no association (OR = 1.56 [95% CI 0.73–3.32], I2 = 72%, P = 0.25) (Fig. 5a).
Stratification by follow-up time
Seven cohort-based studies assessed H. pylori status before CGC diagnosis. Five had follow-up periods of more than five years, whereas two had follow-up periods of less than five years. The pooled analysis of the five studies with follow-up of more than five years showed a statistically significant association between H. pylori infection and CGC (OR = 2.32 [95% CI 1.47–3.66], I2 = 75%, P < 0.001), whereas no statistically significant association was observed in the two studies with follow-up of less than five years (OR = 0.94 [95% CI 0.36–2.46], I2 = 0%, P = 0.90) (Fig. 5b).
Publication bias and sensitivity analysis
Publication bias was evaluated using Begg’s and Egger’s tests. No substantial publication bias was observed (P-value of Begg’s test = 0.980, P-value of Egger’s test = 0.503) (Fig. S1). Furthermore, visual inspection of the funnel plot shapes revealed no significant evidence of asymmetry among the studies (Fig. 6). The study by Kikuchi et al.18 deviated from the line of symmetry, which could be attributed to the study population being primarily composed of patients under the age of 40. We assessed the contribution of each study to the overall pooled OR through a leave-one-out sensitivity analysis. The stability of the results was confirmed, as no single study significantly influenced the pooled OR (Fig. 7). When considered together with the subgroup analysis, the observed heterogeneity may have reflected differences in the definition of CGC, study populations, and H. pylori detection methods.
Discussion
The incidence rate of CGC is increasing in Asian countries. The proportion of CGC in Japan has risen from 2.3% to 10.0% in recent years.41 In high-incidence areas of China, the rate can reach 50/100,000.42 The risk factors and etiology of CGC are debatable but appear to be related to geography and ethnicity. Previous studies have yielded contradictory conclusions about the relationship between H. pylori and CGC.4,43–46 Han et al.4 conducted a meta-analysis that demonstrated a significant association between H. pylori infection and CGC in East Asia, but the analysis included studies using duplicated populations. Moreover, the most recent meta-analysis by Gu et al.47 completed the literature search in December 2021. Recent papers could significantly affect these conclusions. Therefore, we updated the literature and excluded studies using duplicated populations to analyze any new associations between H. pylori and CGC in Asia.
A total of 24 studies were included in our meta-analysis. H. pylori infection was associated with higher odds of CGC (pooled OR = 2.20, 95% CI 1.73–2.80). We also conducted subgroup analyses by country. H. pylori infection was associated with approximately twofold higher odds of CGC in China, Japan, and Korea, whereas no statistically significant association was observed in Iran. Our analysis included only two studies from Iran. Western Asia has much lower age-standardized incidence rates of stomach and esophageal malignancies than Eastern Asia, which ranks first.48 Additionally, several previous studies confirmed a null or negative correlation between H. pylori and CGC in Western populations or low-incidence regions.4,43,44,46 Therefore, the positive association in the present analysis was primarily observed in East Asian populations.
Because of the unique location of the esophagogastric junction (GEJ), CGC is likely a heterogeneous tumor originating from different mucosal types. Internationally, various definitions and classification standards exist. The Siewert classification, proposed in 1987 and extensively used, refers to adenocarcinomas located within 5 cm of the GEJ, including type I (located 1 to 5 cm above the GEJ), type II (located 1 cm above to 2 cm below the GEJ), and type III (located 2 to 5 cm below the GEJ).49 The Kyoto International Consensus Report in 2022 stated that adenocarcinomas within 1 cm of the GEJ should be classified as “cardia cancer”.50 Several studies have found geographical variations in the pathogenesis of CGC. In the West, it is often associated with excessive gastric acid damage caused by gastroesophageal reflux disease, similar to esophageal adenocarcinoma. In East Asia, CGC is associated with gastric mucosal atrophy induced by H. pylori infection, similar to distal gastric cancer.12,51,52 Urabe et al.53 demonstrated that gastric cancers and type III adenocarcinoma of the esophagogastric junction had a similar background mucosal type. Based on survey data from three high-incidence areas in China, the long-term morbidity and mortality risk of CGC increased as the severity of cardia mucosal lesions increased. Trend analysis revealed a positive correlation between the degree of mucosal lesions and the H. pylori infection rate.54 To summarize, severe mucosal atrophy and intestinal metaplasia increase the risk of CGC to some extent. The question of whether its occurrence and development follow the path of Correa needs further exploration. Additionally, the strain type of H. pylori and host susceptibility also play roles in the complex process of carcinogenesis. Current clinical research has found that compared to NCGC, CGC tends to present at a later pTNM stage and has worse clinical outcomes.55 Therefore, identifying risk factors, performing early screening, and implementing interventions are critical in clinical practice.
In addition, the accuracy of H. pylori status is affected by various factors. The first issue involves methodological limitations. In one prospective study, the relationship between H. pylori and the risk of NCGC assessed by immunoblot was more than threefold higher than that assessed by ELISA (enzyme linked immunosorbent assay),56 indicating that detection techniques have different sensitivity levels. Secondly, anti-H. pylori therapy for atrophic gastritis prior to malignancy should be considered. Moreover, both histological infection and serological antibody titers of H. pylori may be cleared or decreased as cancer progresses.39 As a result, the H. pylori infection rate may be underestimated due to the factors described above. We performed a subgroup analysis based on the detection time of H. pylori and found that there was a consistent correlation regardless of detection time, and heterogeneity was not primarily due to this factor. The results from five prospective cohort studies appear to be more reliable. We did not conduct a subgroup analysis of different detection methods because only a few studies employed the immunoblot method.
This meta-analysis has certain limitations. First, although we performed sensitivity analysis to evaluate the stability of the results, the source of heterogeneity remains somewhat difficult to explain. At least half of the studies contributed to the heterogeneity. On the one hand, the criteria for CGC in various studies have not been standardized, resulting in heterogeneity in study populations. Second, various methods were used to detect H. pylori. Studies focusing on younger patients may also have contributed to the heterogeneity. Third, the majority of the included studies were retrospective case-control studies, which are subject to selection bias and confounding variables. The pooled estimates may have been influenced by residual confounding because adjustment for potential confounders varied across the included studies. Although most studies were matched by age and gender, other risk factors, including diet, smoking, alcohol consumption, gastroesophageal reflux disease, and gastrointestinal ulcers, may confound the relationship between H. pylori and CGC.57 Additional adjustments are required for these risk variables. Furthermore, our conclusions primarily focus on East Asian populations due to the lack of sufficient information from countries outside East Asia. Despite the constraints of our study, we updated the latest relevant literature. In addition, we identified and excluded studies using duplicate population cohorts, compared to a prior meta-analysis.4 In summary, H. pylori infection was positively associated with CGC in East Asia; however, the implications of this association for early detection and intervention require further study.
Conclusions
East Asia bears a significant burden of CGC, and H. pylori infection was positively associated with CGC in this region, particularly in China, Japan, and Korea. These findings highlight the potential importance of H. pylori infection in the epidemiology of CGC in East Asia. More well-designed prospective cohort studies are needed to confirm these findings and to determine whether identification and management of H. pylori infection can reduce the incidence of CGC.
Supporting information
Supplementary material for this article is available at https://doi.org/10.14218/CSP.2024.00016.
Table S1
Detailed search strategy in three databases.
(DOCX)
Fig. S1
Begg’s and Egger’s regression tests.
(TIF)
Declarations
Data sharing statement
The datasets used in support of the findings of this study are available from the corresponding author at ruihuashi@126.com upon request.
Funding
None.
Conflict of interest
One of the authors, Prof. Ruihua Shi has been an associate editor of Cancer Screening and Prevention since March 2022. There are no other conflicts of interest regarding the publication of this paper.
Authors’ contributions
Material preparation, data collection, and analysis (YNZ, YD), writing of the first draft of the manuscript (YNZ). All authors contributed to the study’s conception and design and commented on previous versions of the manuscript. All authors read and approved the final manuscript.